Current Research Studies

Cancer – NANT 2015-01: Neuroblastoma Precision Trial

Condition or Therapy:



Cancer and blood disorders

What is the goal of this study?

The goal of this study is to set the platform for a Precison Medicine clinical trial through the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Who can join the study?

This study may be a good fit for children and young adults who:

  • Are 1 to 30 years old and
  • Have been diagnosed with neuroblastoma

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Navin Pinto